BSEBoard Meeting4 Aug 2026 · 4 Aug 2026, 05:15 pm

Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....

Suraksha Diagnostic Ltd · 544293

✦ AI SummaryResults

Suraksha Diagnostic Ltd has informed BSE that a Board meeting is scheduled on 12/08/2026 to consider and approve unaudited financial results for the quarter ended 30 June 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suraksha Diagnostic Ltd - 544293 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

811e082d-a907-4de4-bbc8-ffb27b7814b0.pdf

pdf

Download →
View document text
Date: 04 August 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol : SURAKSHA Dear Sir / Ma’am, Sub: Intimation of Board Meeting under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 12 August, 2026, at the registered office of the Company, to inter-alia, consider and approve the unaudited (standalone and consolidated) financial results of the Company for the quarter ended 30 June 2026. Further, in continuation to our intimation letter dated Monday, 15 June 2026, regarding closure of trading window for the aforesaid purpose, and in accordance with the Company's Internal Code of Conduct for Prohibition of Insider Trading, framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company which was closed from Wednesday, 01 July 2026 for all the directors, KMP’s, designated persons, employees, connected persons and their immediate relatives shall re-open after the expiry of 48 hours from the date of declaration of the said financial results. Please note that this information is also available at the website of the Company at www.surakshanet.com. We request you to take the above on record. Thanking you. For Suraksha Diagnostic Limited Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Suraksha Diagnostic Limited CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750